Celestica (NYSE:CLS) Trading Down 1.9% After Insider Selling

Shares of Celestica, Inc. (NYSE:CLSGet Free Report) (TSE:CLS) dropped 1.9% during mid-day trading on Thursday following insider selling activity. The stock traded as low as $372.06 and last traded at $372.9650. Approximately 2,017,805 shares changed hands during trading, a decline of 17% from the average session volume of 2,418,669 shares. The stock had previously closed at $380.37.

Specifically, CFO Mandeep Chawla sold 17,000 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the transaction, the chief financial officer owned 82,444 shares in the company, valued at $32,948,744.60. The trade was a 17.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Robert Mionis sold 66,056 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $400.06, for a total value of $26,426,363.36. Following the completion of the sale, the chief executive officer directly owned 134,328 shares of the company’s stock, valued at $53,739,259.68. The trade was a 32.96% decrease in their position. The disclosure for this sale is available in the SEC filing. In other news, CEO Robert Mionis sold 55,768 shares of the stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $386.96, for a total value of $21,579,985.28. Following the completion of the sale, the chief executive officer owned 78,560 shares in the company, valued at approximately $30,399,577.60. This trade represents a 41.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Analyst Upgrades and Downgrades

CLS has been the topic of several recent research reports. Barclays boosted their price target on Celestica from $391.00 to $441.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 29th. UBS Group increased their price objective on shares of Celestica from $355.00 to $400.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Susquehanna lifted their price objective on shares of Celestica from $460.00 to $510.00 and gave the company a “positive” rating in a research note on Wednesday, April 29th. Citigroup boosted their target price on shares of Celestica from $338.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, April 29th. Finally, TD upped their target price on shares of Celestica from $330.00 to $350.00 and gave the company a “hold” rating in a research note on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Celestica presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.42.

Check Out Our Latest Stock Analysis on Celestica

Celestica News Summary

Here are the key news stories impacting Celestica this week:

Celestica Price Performance

The company has a 50 day simple moving average of $380.87 and a 200-day simple moving average of $325.89. The stock has a market cap of $42.88 billion, a price-to-earnings ratio of 45.10, a PEG ratio of 0.89 and a beta of 2.02. The company has a quick ratio of 0.73, a current ratio of 1.26 and a debt-to-equity ratio of 0.36.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last released its earnings results on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.08. The company had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. Celestica had a return on equity of 36.91% and a net margin of 6.95%.Celestica’s quarterly revenue was up 52.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.20 EPS. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. As a group, research analysts anticipate that Celestica, Inc. will post 9.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Celestica

Large investors have recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Celestica in the fourth quarter worth $28,000. Ascentis Independent Advisors acquired a new stake in shares of Celestica during the first quarter worth $29,000. Swiss RE Ltd. acquired a new stake in shares of Celestica during the fourth quarter worth $29,000. Cullen Frost Bankers Inc. bought a new position in shares of Celestica in the 4th quarter worth about $30,000. Finally, Sittner & Nelson LLC acquired a new position in shares of Celestica in the 4th quarter valued at about $31,000. 67.38% of the stock is currently owned by institutional investors.

About Celestica

(Get Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

See Also

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.